Cryo Cell International (CCEL) Accumulated Expenses (2010 - 2026)

Cryo Cell International has disclosed Accumulated Expenses across 17 years of filings, most recently posting $2.9 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 33.42% year-over-year to $2.9 million; the TTM figure through Feb 2026 stood at $2.9 million (down 33.42% YoY), while the FY2025 annual figure was $4.3 million, up 101.69% from the prior year.
• Accumulated Expenses fell to $2.9 million in Q1 2026, from $4.3 million in the prior quarter.
• Over the last five years, Accumulated Expenses for CCEL reached as high as $4.3 million in Q1 2025 and fell as low as $1.5 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $2.3 million (2025), against an average of $2.7 million.
• Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 50.43% — and 2025, when it soared 101.69%.
• A 5-year view of Accumulated Expenses shows it stood at $1.5 million in 2022, then jumped by 36.02% to $2.1 million in 2023, then climbed by 2.88% to $2.1 million in 2024, then surged by 101.69% to $4.3 million in 2025, then slumped by 32.51% to $2.9 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $2.9 million, $4.3 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.